Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:1917-1922

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lynch, J. J.
Right arrow Articles by Billman, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lynch, J. J., Jr
Right arrow Articles by Billman, G. E.
Related Collections
Right arrow Animal models of human disease
Right arrow Arrythmias-basic studies
Right arrow Ion channels/membrane transport

(Circulation. 1999;100:1917-1922.)
© 1999 American Heart Association, Inc.


Basic Science Reports

Antiarrhythmic Efficacy of Selective Blockade of the Cardiac Slowly Activating Delayed Rectifier Current, IKs, in Canine Models of Malignant Ischemic Ventricular Arrhythmia

Joseph J. Lynch, Jr, PhD; Melanie S. Houle, MS; Gary L. Stump, BS; Audrey A. Wallace, BS; David B. Gilberto, DVM; Hossain Jahansouz, PhD; Garry R. Smith, BS; Andrew J. Tebben, MS; Nigel J. Liverton, PhD; Harold G. Selnick, PhD; David A. Claremon, PhD; George E. Billman, PhD

From the Departments of Pharmacology, Laboratory Animal Medicine, Pharmaceutical Research and Development, and Medicinal Chemistry, Merck Research Laboratories, West Point, Pa, and the Department of Physiology, The Ohio State University, Columbus.

Correspondence to Dr Joseph J. Lynch, Jr, WP46-300, Merck Research Laboratories, West Point, PA 19486.

Background—To date, the lack of potent and selective inhibitors has hampered the physiological assessment of modulation of the cardiac slowly activating delayed rectifier current, IKs. The present study, using the IKs blocker L-768,673, represents the first in vivo assessment of the cardiac electrophysiological and antiarrhythmic effects of selective IKs blockade.

Methods and Results—In an anesthetized canine model of recent (8.5±0.4 days) anterior myocardial infarction, 0.003 to 0.03 mg/kg L-768,673 IV significantly suppressed electrically induced ventricular tachyarrhythmias and reduced the incidence of lethal arrhythmias precipitated by acute, thrombotically induced posterolateral myocardial ischemia. Antiarrhythmic protection afforded by L-768,673 was accompanied by modest 7% to 10% increases in noninfarct zone ventricular effective refractory period, 3% to 5% increases in infarct zone ventricular effective refractory period, and 4% to 6% increases in QTc interval. In a conscious canine model of healed (3 to 4 weeks) anterior myocardial infarction, ventricular fibrillation was provoked by transient occlusion of the left circumflex coronary artery during submaximal exercise. Pretreatment with 0.03 mg/kg L-768,673 IV elicited a modest 7% increase in QTc, prevented ventricular fibrillation in 5 of 6 animals, and suppressed arrhythmias in 2 additional animals.

Conclusions—The present findings suggest that selective blockade of IKs may be a potentially useful intervention for the prevention of malignant ischemic ventricular arrhythmias.


Key Words: antiarrhythmia agents • arrhythmia • myocardial infarction • fibrillation




This article has been cited by other articles:


Home page
CirculationHome page
P. G.A. Volders, M. Stengl, J. M. van Opstal, U. Gerlach, R. L.H.M.G. Spatjens, J. D.M. Beekman, K. R. Sipido, and M. A. Vos
Probing the Contribution of IKs to Canine Ventricular Repolarization: Key Role for {beta}-Adrenergic Receptor Stimulation
Circulation, June 3, 2003; 107(21): 2753 - 2760.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. J. Lynch Jr., J. J. Salata, A. A. Wallace, G. L. Stump, D. B. Gilberto, H. Jahansouz, N. J. Liverton, H. G. Selnick, and D. A. Claremon
Antiarrhythmic Efficacy of Combined IKs and beta -Adrenergic Receptor Blockade
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 283 - 289.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Kang, X.-L. Chen, L. Wang, and D. Rampe
Interactions of the Antimalarial Drug Mefloquine with the Human Cardiac Potassium Channels KvLQT1/minK and HERG
J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 290 - 296.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
X. Xu, S. J. Rials, Y. Wu, J. J. Salata, T. Liu, D. B. Bharucha, R. A. Marinchak, and P. R. Kowey
Left Ventricular Hypertrophy Decreases Slowly but Not Rapidly Activating Delayed Rectifier Potassium Currents of Epicardial and Endocardial Myocytes in Rabbits
Circulation, March 20, 2001; 103(11): 1585 - 1590.
[Abstract] [Full Text] [PDF]